Lördag 21 December | 12:53:16 Europe / Stockholm
Svenska | English

Gentian Diagnostics

Kalender

Tid*
2025-10-23 08:00 Kvartalsrapport 2025-Q3
2025-07-10 08:00 Kvartalsrapport 2025-Q2
2025-05-07 08:00 Kvartalsrapport 2025-Q1
2025-05-06 N/A Årsstämma
2025-02-12 08:30 Bokslutskommuniké 2024
2024-10-31 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-04-30 - Kvartalsrapport 2024-Q1
2024-04-30 - X-dag ordinarie utdelning GENT 0.00 NOK
2024-04-29 - Årsstämma
2024-02-09 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-05 - Kvartalsrapport 2023-Q1
2023-05-05 - X-dag ordinarie utdelning GENT 0.00 NOK
2023-05-04 - Årsstämma
2023-02-16 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning GENT 0.00 NOK
2022-05-18 - Årsstämma
2022-04-28 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-10-21 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-05 - X-dag ordinarie utdelning GENT 0.00 NOK
2021-05-04 - Årsstämma
2021-04-16 - Kvartalsrapport 2021-Q1
2021-02-11 - Bokslutskommuniké 2020
2020-10-29 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning GENT 0.00 NOK
2020-05-14 - Årsstämma
2020-04-24 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-21 - Extra Bolagsstämma 2019
2019-05-10 - X-dag ordinarie utdelning GENT 0.00 NOK
2018-07-13 - Extra Bolagsstämma 2018
2018-06-13 - X-dag ordinarie utdelning GENT 0.00 NOK
2018-02-27 - Bokslutskommuniké 2017
2017-06-06 - Årsstämma

Beskrivning

LandNorge
ListaOB Match
SektorHälsovård
IndustriBioteknik
Gentian Diagnostics är ett medicinskt diagnostikbolag som utvecklar och tillverkar in vitro diagnostiska reagenser för högkapacitetsanalysatorer. Gentians expertis och fokus ligger inom homogena immunanalyser, speciellt infektioner, inflammationer, njursvikt och kongestiv hjärtsvikt. Bolagets huvudkontor och produktionsanläggningar finns i Moss, Norge, och betjänar den globala human- och veterinärdiagnostikmarknaden genom försäljnings- och representationskontor i nyckelländer.
Filter arrow-icon
År arrow-icon
Typ arrow-icon
Språk arrow-icon
Rensa
Se endast PM som skrivits på följande språk
Se endast PM som skrivits från valt år
Se endast PM som skrivits på följande språk
2024-12-16 14:09:26 GENT: Mandatory notification of trade 39,20 NOK | +0,51%  | 0,09 MNOK pdf download
2024-12-04 10:01:50 GENT: Financial calendar 40,00 NOK | +1,01%  | 0,73 MNOK
2024-11-26 10:58:28 GENT: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 41,40 NOK | +3,50%  | 0,17 MNOK pdf download
2024-10-31 08:00:00 Gentian Diagnostics: Third quarter 2024 report 43,60 NOK | -1,36%  | 0,03 MNOK pdf download pdf download
2024-10-24 08:30:00 Gentian Diagnostics: Invitation to presentation of third quarter results 42,20 NOK | +1,44%  | 0,03 MNOK
2024-08-29 08:00:00 Gentian Diagnostics: Second quarter 2024 report 52,50 NOK | -0,94%  | 0,34 MNOK pdf download pdf download
2024-08-22 10:00:00 Gentian Diagnostics: Invitation to presentation of second quarter results 53,00 NOK | -1,85%  | 0,06 MNOK
2024-08-05 11:20:27 GENT: Appointment of Chief Technology Officer 56,00 NOK | 0,00%  | 0,42 MNOK
2024-07-31 08:30:00 GENT: Gentian Diagnostics presents its NT-proBNP prototype at the ADLM 59,00 NOK | +0,85%  | 0,21 MNOK pdf download
2024-07-22 14:21:41 GENT: Matti Heinonen (Arvela) appointed as CEO of Gentian Diagnostics 56,00 NOK | +3,70%  | 1,48 MNOK pdf download
2024-06-28 11:02:21 GENT: Groundbreaking assay development for measuring total NT-proBNP levels 54,00 NOK | +20,00%  | 5,10 MNOK
2024-06-28 08:34:31 Gentian Diagnostics: NT-proBNP successful completion of optimisation phase 54,00 NOK | +20,00%  | 5,10 MNOK
2024-05-02 14:09:26 Gentian Diagnostics: Mandatory notificaton of trade 38,60 NOK | -5,39%  | 12,1 MNOK
2024-04-30 08:00:00 Gentian Diagnostics: First quarter 2024 report 40,80 NOK | +2,51%  | 13,8 MNOK
2024-04-29 14:20:12 Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors 39,80 NOK | +8,15%  | 0,61 MNOK
2024-04-29 13:33:51 Gentian Diagnostics: Minutes from Annual General Meeting 39,80 NOK | +8,15%  | 0,61 MNOK
2024-04-24 09:46:16 Gentian Diagnostics: Invitation to presentation of first quarter results 37,60 NOK | 0,00%  | 0,10 MNOK
2024-03-21 09:15:00 Gentian Diagnostics: Notice of annual general meeting 38,30 NOK | +1,32%  | 0,11 MNOK
2024-03-21 09:15:00 Gentian Diagnostics: CEO resignation 38,30 NOK | +1,32%  | 0,11 MNOK
2024-03-21 08:30:00 Gentian Diagnostics: Annual report 2023 38,30 NOK | +1,32%  | 0,11 MNOK
2024-03-13 15:11:54 GENT: New KDIGO Guidelines recommends increased use of cystatin C 38,70 NOK | -0,26%  | 0,00 MNOK
2024-02-09 08:00:00 GENT: Fourth quarter and full year 2023 report 41,90 NOK | -2,56%  | 2,11 MNOK
2024-01-30 14:04:07 GENT: Invitation to presentation of fourth quarter results 41,00 NOK | 0,00%  | 0,02 MNOK
2023-12-19 14:13:36 GENT: Disclosure of shareholding 38,90 NOK | -2,75%  | 0,41 MNOK
2023-12-18 09:23:37 GENT: Resignation of board member 40,00 NOK | +0,50%  | 0,04 MNOK
2023-12-14 09:24:03 GENT: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 39,00 NOK | 0,00%  | 6,08 MNOK
2023-12-11 13:29:01 GENT: Financial calendar 39,10 NOK | +0,26%  | 0,02 MNOK
2023-11-24 10:07:59 GENT: Mandatory notification of trade 39,90 NOK | -2,44%  | 0,05 MNOK
2023-10-26 08:00:00 GENT: Third quarter 2023 report 40,00 NOK | -1,96%  | 0,15 MNOK
2023-10-18 12:19:14 GENT: Invitation to presentation of third quarter results 41,50 NOK | +1,22%  | 0,23 MNOK
2023-08-29 13:55:29 GENT: Mandatory notification of trade 43,00 NOK | -2,05%  | 0,46 MNOK
2023-08-24 08:00:00 GENT: Second quarter 2023 report 43,20 NOK | -2,70%  | 0,31 MNOK
2023-08-16 09:34:48 GENT: Invitation to presentation of second quarter results 44,90 NOK | 0,00%  | 0,01 MNOK
2023-06-15 08:38:12 GENT: Gentian acquires Getica for SEK 3.0 million 47,70 NOK | +4,15%  | 0,33 MNOK
2023-05-10 10:42:30 GENT: Capital Markets Day at 12.30 CEST today 47,70 NOK | 0,00%  | 0,03 MNOK
2023-05-08 14:41:19 Reminder: Invitation to Capital Markets Day 10 May 2023 47,90 NOK | +0,84%  | 0,01 MNOK
2023-05-05 17:25:36 Disclosure of shareholdings - Holta Invest AS 47,90 NOK | +0,84%
2023-05-05 17:05:46 GENT: Mandatory notification of trade 47,90 NOK | +0,84%
2023-05-05 07:30:00 GENT: First quarter 2023 report 47,50 NOK | 0,00%
2023-05-04 11:18:21 GENT: Minutes from Annual General Meeting 47,50 NOK | +2,15%  | 0,01 MNOK
2023-04-27 10:55:58 GENT: Invitation to presentation of first quarter results 46,00 NOK | -7,07%  | 0,15 MNOK
2023-04-14 09:24:39 GENT: Gentian Diagnostics invites to Capital Markets Day 39,40 NOK | +1,03%  | 0,24 MNOK
2023-04-12 13:12:08 GENT: Notice of annual general meeting 39,00 NOK | +0,26%  | 0,22 MNOK
2023-03-30 16:48:43 GENT: Annual report 2022 38,80 NOK | 0,00%
2023-03-22 13:52:27 GENT: Health economic model identifies GCAL® as a cost-effective biomarker 39,00 NOK | 0,00%  | 0,04 MNOK
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden